Lundbeck Still Assessing Future Of Antipsychotic After Phase III Failure, Says CEO

 
• By Jo Shorthouse
Video interview
Lundbeck CEO Deborah Dunsire Talks To Scrip At BIO-Europe 2018 • Source: Shutterstock

More from Neurological

More from Therapeutic Category